Table 1.
Sham | Saline | TCZ (mg/kg) |
P-Value | ||||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 4 | 8 | 16 | 32 | ||||
Surgical Difficulty | |||||||||
Tooth Mass (mg) | 0.0 ± 0.0 | 16.0 ± 0.6∗ | 16.1 ± 0.9 | 15.9 ± 0.8 | 14.7 ± 0.9 | 14.5 ± 0.1 | 15.6 ± 0.8 | 16.9 ± 1.0 | <.001 |
Radicular Fractures (n) | 0.0 ± 0.0 | 0.6 ± 0.2∗ | 1.0 ± 0.3 | 0.8 ± 0.4 | 1.0 ± 0.4 | 1.0 ± 0.0 | 0.7 ± 0.2 | 0.8 ± 0.3 | .043 |
Ratio final/initial blood cells counting (%) | |||||||||
Withe Blood Cells | 124.9 ± 15.0 | 122.1 ± 6.6 | 125.9 ± 7.7 | 109.2 ± 14.6 | 102.5 ± 4.0 | 89.2 ± 3.3∗,† | 88.7 ± 12.1∗,† | 87.7 ± 11.9∗,† | .039 |
Lymphocytes | 124.5 ± 16.8 | 121.6 ± 6.5 | 129.7 ± 12.0 | 110.5 ± 14.8 | 103.8 ± 3.3 | 94.0 ± 3.8 | 98.6 ± 17.1 | 87.2 ± 15.6 | .310 |
Myeloid cells | 125.1 ± 14.0 | 98.1 ± 12.2 | 61.6 ± 14.6 | 74.3 ± 5.1 | 79.9 ± 10.5 | 66.9 ± 9.2 | 34.0 ± 7.1∗,† | 29.1 ± 4.9∗,† | <.001 |
Systemic parameters of toxicity | |||||||||
Body mass (%) | 102.7 ± 1.9 | 105.2 ± 1.1 | 104.6 ± 1.8 | 106.7 ± 1.6 | 105.8 ± 0.8 | 100.2 ± 1.2 | 96.60 ± 1.3∗,† | 96.40 ± 3.2∗,† | <.001 |
Liver Index (%) | 4.96 ± 0.39 | 5.34 ± 0.27 | 5.01 ± 0.23 | 5.22 ± 0.27 | 4.81 ± 0.31 | 4.23 ± 0.22 | 4.01 ± 0.11† | 3.92 ± 0.15∗,† | .001 |
Spleen Index (%) | 0.29 ± 0.05 | 0.30 ± 0.05 | 0.29 ± 0.03 | 0.28 ± 0.03 | 0.28 ± 0.03 | 0.28 ± 0.04 | 0.29 ± 0.06 | 0.27 ± 0.08 | .972 |
Renal Index (%) | 0.47 ± 0.04 | 0.47 ± 0.01 | 0.45 ± 0.01 | 0.49 ± 0.02 | 0.44 ± 0.02 | 0.42 ± 0.01 | 0.48 ± 0.03 | 0.45 ± 0.02 | .420 |
Organs mass calculated by the ratio between the weight of each organ and weight of rat on euthanasia day.
Body mass variation calculated by the ratio between final/initial weight. Bold values indicate significant P-values.
Abbreviation: TCZ, Tocilizumab.
P < .5 versus Sham group.
P < .5 versus saline group.